HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$7.29
Day range
$7.29 - $7.94
Year range
$4.32 - $11.36
Market cap
182.43M USD
Avg Volume
249.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 50.00K | 257.14% |
Operating expense | 9.96M | -9.75% |
Net income | -9.74M | 11.66% |
Net profit margin | -19.48K | 75.27% |
Earnings per share | -0.43 | 29.51% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.34M | -25.63% |
Total assets | 37.80M | -19.29% |
Total liabilities | 8.13M | -54.36% |
Total equity | 29.67M | — |
Shares outstanding | 23.21M | — |
Price to book | 5.65 | — |
Return on assets | -64.02% | — |
Return on capital | -79.24% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.74M | 11.66% |
Cash from operations | -6.82M | 8.72% |
Cash from investing | — | — |
Cash from financing | 5.27M | 310.96% |
Net change in cash | -1.58M | 83.90% |
Free cash flow | -3.30M | 7.86% |
About
Founded
2015
Headquarters
Website
Employees
18
